-
EP2945642
European procedure
Extract from the Register of European Patents
EP About this file: EP2945642
| EP2945642 - FACTOR 1 PROTEIN FOR USE IN TREATING OR PREVENTING DISEASES [Right-click to bookmark this link] | |||
| Former [2015/48] | FACTOR 1 PROTEIN, FACTOR 2 PROTEIN AND INHIBITORS THEREOF FOR USE IN TREATING OR PREVENTING DISEASES | ||
| [2022/31] | Status | The patent has been granted Status updated on 19.01.2024 Database last updated on 19.10.2024 | |
| Former | Grant of patent is intended Status updated on 08.05.2023 | ||
| Former | Examination is in progress Status updated on 18.11.2022 | ||
| Former | Grant of patent is intended Status updated on 11.07.2022 | ||
| Former | Examination is in progress Status updated on 23.11.2018 | Most recent event Tooltip | 18.10.2024 | Lapse of the patent in a contracting state | published on 20.11.2024 [2024/47] | Applicant(s) | For all designated states Medizinische Hochschule Hannover Carl-Neuberg-Strasse 1 30625 Hannover / DE | [2015/48] | Inventor(s) | 01 /
WOLLERT, Kai Christoph Richard-Wagner-Strasse 19 30177 Hannover / DE | 02 /
KORF-KLINGEBIEL, Mortimer Nesselröder Strasse 14 37115 Duderstadt / DE | [2015/48] | Representative(s) | Zwicker, Jörk ZSP Patentanwälte PartG mbB Hansastraße 32 80686 München / DE | [2024/08] |
| Former [2015/48] | Zwicker, Jörk ZSP Patentanwälte Partnerschaftsgesellschaft Radlkoferstrasse 2 81373 München / DE | Application number, filing date | 14700872.6 | 16.01.2014 | [2015/48] | WO2014EP50788 | Priority number, date | EP20130151593 | 17.01.2013 Original published format: EP 13151593 | [2015/48] | Filing language | EN | Procedural language | EN | Publication | Type: | A2 Application without search report | No.: | WO2014111458 | Date: | 24.07.2014 | Language: | EN | [2014/30] | Type: | A2 Application without search report | No.: | EP2945642 | Date: | 25.11.2015 | Language: | EN | The application published by WIPO in one of the EPO official languages on 24.07.2014 takes the place of the publication of the European patent application. | [2015/48] | Type: | B1 Patent specification | No.: | EP2945642 | Date: | 21.02.2024 | Language: | EN | [2024/08] | Search report(s) | International search report - published on: | EP | 12.09.2014 | Classification | IPC: | A61K38/17, C12N15/86, A61K38/18, A61K31/7088, A61K9/00, A61P9/00, A61P9/04, A61P9/10, A61P17/06, A61P19/02, A61P27/02, A61P29/00, A61P31/00, A61P35/00, A61P43/00, A61P17/02 | [2022/31] | CPC: |
A61K38/18 (EP,US);
A61K31/7088 (EP,US);
A61K38/1709 (EP,US);
A61K38/177 (EP,US);
A61K9/0019 (EP,US);
A61P17/02 (EP);
A61P17/06 (EP);
A61P19/02 (EP);
A61P27/02 (EP);
A61P29/00 (EP);
A61P31/00 (EP);
A61P35/00 (EP);
A61P43/00 (EP);
A61P9/00 (EP);
A61P9/04 (EP);
A61P9/10 (EP);
C07K16/22 (US);
C07K16/28 (US);
|
| Former IPC [2015/48] | A61K38/17, A61K9/00, A61K31/7088, C12N15/86, A61P9/00, A61P9/10 | Designated contracting states | AL, AT, BE, BG, CH, CY, CZ, DE, DK, EE, ES, FI, FR, GB, GR, HR, HU, IE, IS, IT, LI, LT, LU, LV, MC, MK, MT, NL, NO, PL, PT, RO, RS, SE, SI, SK, SM, TR [2015/48] | Extension states | BA | Not yet paid | ME | Not yet paid | Title | German: | FAKTOR-1-PROTEIN ZUR VERWENDUNG BEI DER BEHANDLUNG UND PRÄVENTION VON ERKRANKUNGEN | [2022/31] | English: | FACTOR 1 PROTEIN FOR USE IN TREATING OR PREVENTING DISEASES | [2022/31] | French: | PROTÉINE DU FACTEUR 1 DESTINÉ À ÊTRE UTILISÉS DANS LE TRAITEMENT OU LA PRÉVENTION DE MALADIES | [2022/31] |
| Former [2015/48] | FAKTOR-1-PROTEIN, FAKTOR-2-PROTEIN UND INHIBITOREN DAVON ZUR VERWENDUNG BEI DER BEHANDLUNG UND PRÄVENTION VON ERKRANKUNGEN | ||
| Former [2015/48] | FACTOR 1 PROTEIN, FACTOR 2 PROTEIN AND INHIBITORS THEREOF FOR USE IN TREATING OR PREVENTING DISEASES | ||
| Former [2015/48] | PROTÉINE DU FACTEUR 1, PROTÉINE DU FACTEUR 2 ET LEURS INHIBITEURS DESTINÉS À ÊTRE UTILISÉS DANS LE TRAITEMENT OU LA PRÉVENTION DE MALADIES | Entry into regional phase | 10.08.2015 | National basic fee paid | 10.08.2015 | Designation fee(s) paid | 10.08.2015 | Examination fee paid | Examination procedure | 10.08.2015 | Amendment by applicant (claims and/or description) | 10.08.2015 | Examination requested [2015/48] | 22.11.2018 | Despatch of a communication from the examining division (Time limit: M04) | 08.03.2019 | Reply to a communication from the examining division | 30.09.2019 | Despatch of a communication from the examining division (Time limit: M08) | 14.09.2020 | Reply to a communication from the examining division | 16.09.2021 | Despatch of a communication from the examining division (Time limit: M06) | 28.03.2022 | Reply to a communication from the examining division | 12.07.2022 | Communication of intention to grant the patent | 17.11.2022 | Disapproval of the communication of intention to grant the patent by the applicant or resumption of examination proceedings by the EPO | 22.12.2022 | Despatch of a communication from the examining division (Time limit: M04) | 06.04.2023 | Reply to a communication from the examining division | 09.05.2023 | Communication of intention to grant the patent | 11.10.2023 | Despatch of communication that the application is deemed to be withdrawn, reason: fee for grant / fee for printing not paid in time | 13.12.2023 | Fee for grant paid | 13.12.2023 | Fee for publishing/printing paid | 13.12.2023 | Receipt of the translation of the claim(s) | Divisional application(s) | EP20178045.9 / EP3747457 | The date of the Examining Division's first communication in respect of the earliest application for which a communication has been issued is 22.11.2018 | Request for further processing for: | The application is deemed to be withdrawn due to failure to fulfill actions required for granting the patent | 13.12.2023 | Request for further processing filed | 13.12.2023 | Full payment received (date of receipt of payment) Request granted | 22.12.2023 | Decision despatched | The application is deemed to be withdrawn due to failure to reply to the examination report | 14.09.2020 | Request for further processing filed | 14.09.2020 | Full payment received (date of receipt of payment) Request granted | 23.09.2020 | Decision despatched | Fees paid | Renewal fee | 29.01.2016 | Renewal fee patent year 03 | 25.01.2017 | Renewal fee patent year 04 | 31.01.2018 | Renewal fee patent year 05 | 31.01.2019 | Renewal fee patent year 06 | 28.01.2020 | Renewal fee patent year 07 | 18.01.2021 | Renewal fee patent year 08 | 24.01.2022 | Renewal fee patent year 09 | 23.01.2023 | Renewal fee patent year 10 | 16.01.2024 | Renewal fee patent year 11 |
| Opt-out from the exclusive Tooltip competence of the Unified Patent Court | See the Register of the Unified Patent Court for opt-out data | ||
| Responsibility for the accuracy, completeness or quality of the data displayed under the link provided lies entirely with the Unified Patent Court. | Lapses during opposition Tooltip | SM | 21.02.2024 | [2024/47] | Cited in | International search | [X]WO02081681 ; | [X]KR20120095063 ; | [X]WO9811217 (SAGAMI CHEM RES [JP], et al); | [A]US2003166547 (OLIVIERO SALVATORE [IT]); | [XI]US2004185049 (HUNTER CHRISTOPHER [US], et al); | [X]US2004214229 (BERGAMNN ANDREAS [DE], et al); | [A]US2007160985 (GALLAHER TIMOTHY K [US], et al); | [XI]EP2130547 (GIULIANI INT LTD [IT]); |